Eli Lilly & Company has recalled 700 vials of Sterile Diluent used with Humalog U-100 (insulin lispro), Humulin R U-100 (insulin human), and Insulin Lispro Injection U-100 (10 mL). The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations, which are failures to meet required manufacturing standards. Consumers should check their 10 mL vials for batch number D608951C with an expiration date of April 10, 2025. If you have this affected batch, contact your healthcare provider or pharmacist to discuss alternative options or a replacement.
Deviations in manufacturing processes can lead to quality and safety concerns for sterile products. While no specific injuries have been reported, using a diluent that does not meet strict quality standards could potentially impact the effectiveness or safety of the insulin treatment.
You have 2 options:
Marketed by Lilly USA, LLC. Total of 700 vials affected.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.